Senti BiosciencesSNTI
13F holders, Q4 2024 (December 31)1holders −1
0new positions
1sold out
$3.51avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Senti Biosciences Inc. (SNTI) in their 13F filings, down 1 from Q3 2024. 0 opened new positions and 1 sold out. The largest holder was 8VC GP I, LLC ($891K).
- Company
- Senti Biosciences Inc.
- CUSIP
- 81726A100
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $109K |
All 13F filers, Q3 2024 → Q4 2024: 48,048 shares sold, net −48,048 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| 8VC GP I, LLC | 1.13% | No change | 253,755 | $891K |
"% of holder's portfolio" is SNTI's weight in each manager's 13F, not the share of Senti Biosciences Inc. the manager owns.